Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Skeletal muscle atrophy, Delayed speech and language development, Delayed ability to walk, and Feeding difficulties and others; and common findings: Achilles tendon contracture, Microcephaly, and Inner ear hearing loss (sensorineural hearing impairment). 21 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 7 | Delayed speech and language development, Dysarthria, Global developmental delay |
MARS1 encodes methionyl-tRNA synthetase 1 (900 aa). Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. Highest expression in Cells Cultured fibroblasts (114.2 TPM) and Brain Cerebellum (111.3 TPM).
Spastic paraplegia 70, autosomal recessive is associated with mutations in the MARS1 gene on chromosome 12.
MARS1 is classified as a druggable target (Druggable Genome and Enzyme categories) with score 0.0.
Genetic testing for MARS1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 14 always present features, 3 common features.
No clinical trials have been registered for spastic paraplegia 70, autosomal recessive.
5 publications have been identified in PubMed for spastic paraplegia 70, autosomal recessive. Research spans Case Report / Case Series (40%), Review / Meta-Analysis (20%), and Basic Science / Preclinical (20%).
Asahi Y (2026). [PMID: 41791722](https://pubmed.ncbi.nlm.nih.gov/41791722/). *Anesth Prog*. [Case Report / Case Series]
Agianda HAP (2026). [PMID: 41365832](https://pubmed.ncbi.nlm.nih.gov/41365832/). *Mov Disord*. [Epidemiology / Natural History]
Esmaeil Lashgarian H (2026). [PMID: 41625348](https://pubmed.ncbi.nlm.nih.gov/41625348/). *Iran J Med Sci*. [Case Report / Case Series]
Rossi S (2026). [PMID: 41686260](https://pubmed.ncbi.nlm.nih.gov/41686260/). *Neurol Sci*. [Review / Meta-Analysis]
Maroofian R (2024). [PMID: 38527963](https://pubmed.ncbi.nlm.nih.gov/38527963/). *Brain*. [Basic Science / Preclinical]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:57 PM UTC
Online Mendelian Inheritance in Man
Muscles | 3 | Skeletal muscle atrophy, Achilles tendon contracture, Fasciculations |
Bones and joints | 2 | Skeletal muscle atrophy, Sideways curvature of the spine (scoliosis) |
Head and neck | 2 | Microcephaly, High palate |
Digestive system | 1 | Feeding difficulties |
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |
Growth and development | 1 | Growth delay |